Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016583 |
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
AKR1C2 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | increases metabolic processing | 11306090
|
C005399 |
9,10-phenanthrenequinone |
AKR1C2 protein results in increased metabolism of 9,10-phenanthrenequinone | increases metabolic processing | 17950253
|
D004092 |
20-alpha-Dihydroprogesterone |
AKR1C2 protein results in increased chemical synthesis of 20-alpha-Dihydroprogesterone | increases chemical synthesis | 11158055
|
D013196 |
Dihydrotestosterone |
AKR1C2 protein results in increased metabolism of and results in decreased activity of Dihydrotestosterone | decreases activity|increases metabolic processing | 17170221
|
D013196 |
Dihydrotestosterone |
AKR1C2 protein results in increased reduction of Dihydrotestosterone | increases reduction | 11158055
|
D015113 |
Androstane-3,17-diol |
AKR1C2 protein results in increased chemical synthesis of Androstane-3,17-diol | increases chemical synthesis | 11158055 17170221
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite results in decreased expression of AKR1C2 mRNA | decreases expression | 18687144
|
D001564 |
Benzo(a)pyrene |
AKR1C2 protein affects the susceptibility to Benzo(a)pyrene | affects response to substance | 19800895
|
D001564 |
Benzo(a)pyrene |
AKR1C2 protein affects the susceptibility to [Benzo(a)pyrene co-treated with methylparaoxon] | affects cotreatment|affects response to substance | 19800895
|
D001564 |
Benzo(a)pyrene |
AKR1C2 protein affects the susceptibility to [Benzo(a)pyrene co-treated with Methyl Parathion] | affects cotreatment|affects response to substance | 19800895
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene promotes the reaction [Methyl Parathion results in increased activity of AKR1C2 protein] | increases activity|increases reaction | 19800895
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of AKR1C2 mRNA | increases expression | 19800895 15735009 20106945
|
D001564 |
Benzo(a)pyrene |
Methyl Parathion promotes the reaction [Benzo(a)pyrene results in increased expression of AKR1C2 mRNA] | increases expression|increases reaction | 19800895
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of AKR1C2 mRNA | increases expression | 19150397
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of AKR1C2 mRNA | increases expression | 12414654 15336504
|
D002104 |
Cadmium |
Cadmium results in increased expression of AKR1C2 mRNA | increases expression | 21172416
|
D002635 |
Chenodeoxycholic Acid |
Chenodeoxycholic Acid binds to AKR1C2 protein | affects binding | 8486699
|
D003630 |
Daunorubicin |
Daunorubicin results in increased activity of AKR1C2 protein | increases activity | 15588138
|
D004178 |
Diquat |
Diquat results in increased expression of AKR1C2 mRNA | increases expression | 21172416
|
C108373 |
dutasteride |
dutasteride results in increased expression of AKR1C2 mRNA | increases expression | 16806904
|
D004958 |
Estradiol |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of AKR1C2 mRNA | affects cotreatment|decreases expression | 19619570
|
D004958 |
Estradiol |
Estradiol results in increased expression of AKR1C2 mRNA | increases expression | 19619570
|
D005472 |
Fluorouracil |
AKR1C2 protein affects the susceptibility to Fluorouracil | affects response to substance | 16217747
|
C106014 |
gedunin |
gedunin results in increased expression of AKR1C2 mRNA | increases expression | 17010675
|
C071834 |
glycidamide |
glycidamide results in increased expression of AKR1C2 mRNA | increases expression | 17822822
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of AKR1C2 mRNA | affects cotreatment|increases expression | 17183730
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in increased expression of AKR1C2 mRNA | increases expression | 12414654
|
D008095 |
Lithocholic Acid |
Lithocholic Acid binds to AKR1C2 protein | affects binding | 8486699
|
D008294 |
Malathion |
Malathion results in increased expression of AKR1C2 mRNA | increases expression | 16079077
|
C008480 |
methylparaoxon |
AKR1C2 protein affects the susceptibility to [Benzo(a)pyrene co-treated with methylparaoxon] | affects cotreatment|affects response to substance | 19800895
|
C008480 |
methylparaoxon |
methylparaoxon results in increased expression of AKR1C2 mRNA | increases expression | 19800895
|
D008743 |
Methyl Parathion |
AKR1C2 protein affects the susceptibility to [Benzo(a)pyrene co-treated with Methyl Parathion] | affects cotreatment|affects response to substance | 19800895
|
D008743 |
Methyl Parathion |
Benzo(a)pyrene promotes the reaction [Methyl Parathion results in increased activity of AKR1C2 protein] | increases activity|increases reaction | 19800895
|
D008743 |
Methyl Parathion |
Methyl Parathion promotes the reaction [Benzo(a)pyrene results in increased expression of AKR1C2 mRNA] | increases expression|increases reaction | 19800895
|
D008743 |
Methyl Parathion |
Methyl Parathion results in increased activity of AKR1C2 protein | increases activity | 19800895
|
D008743 |
Methyl Parathion |
Methyl Parathion results in increased expression of AKR1C2 mRNA | increases expression | 19800895
|
D017239 |
Paclitaxel |
AKR1C2 mRNA results in increased susceptibility to Paclitaxel | increases response to substance | 16322897
|
C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid results in decreased expression of AKR1C2 mRNA | decreases expression | 17681415
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of AKR1C2 mRNA | decreases expression | 18467677
|
C006253 |
pirinixic acid |
PPARA protein promotes the reaction [pirinixic acid results in decreased expression of AKR1C2 mRNA] | decreases expression|increases reaction | 18467677
|
D011374 |
Progesterone |
AKR1C2 protein results in increased reduction of Progesterone | increases reduction | 11158055
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of AKR1C2 mRNA | increases expression | 19696165
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of AKR1C2 protein | increases expression | 19696165
|
D014284 |
Triiodothyronine |
Triiodothyronine results in increased expression of AKR1C2 mRNA | increases expression | 15507505
|
C004648 |
testosterone enanthate |
testosterone enanthate affects the expression of AKR1C2 mRNA | affects expression | 17440010
|
D013749 |
Tetrachlorodibenzodioxin |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of AKR1C2 mRNA | affects cotreatment|decreases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of AKR1C2 mRNA | decreases expression | 19619570
|
C050414 |
tripterine |
tripterine results in increased expression of AKR1C2 mRNA | increases expression | 17010675
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of AKR1C2 mRNA | affects cotreatment|increases expression | 17183730
|
D014810 |
Vitamin E |
Vitamin E results in increased expression of AKR1C2 mRNA | increases expression | 19244175
|
D024483 |
Vitamin K 3 |
Vitamin K 3 results in increased expression of AKR1C2 mRNA | increases expression | 12414654
|
D019287 |
Zinc Sulfate |
Zinc Sulfate results in increased expression of AKR1C2 mRNA | increases expression | 16330358
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
7.05 | 15322242 14514962 11752688 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
7.05 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.59 | 19490988 |
MESH:D000138 |
Acidosis |
|
Zinc Sulfate |
4.53 | 7265320 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.77 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
6.45 | 20464547 20127859 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
6.45 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
6.45 | 17638652 |
MESH:D000236 |
Adenoma |
|
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
6.26 | 16176798 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
6.26 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
8.63 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
8.63 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.31 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.51 | 16712894 17306315 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Malathion |
4.60 | 17119214 11874814 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
4.84 | 17688650 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
7.59 | 17963324 16511603 15504547 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
7.59 | 11748828 |
MESH:D000860 |
Anoxia |
|
Zinc Sulfate |
4.64 | 7265320 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.27 | 17497229 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.70 | 19183758 |
MESH:D050197 |
Atherosclerosis |
|
Cadmium |
3.42 | 15687053 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.05 | 17157402 18316065 16609825 17507914 18775368 18940202 17688650 20603192 19232924 18558336 18177632 18985861 19460635 15238991 18396377 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
2.88 | 17594078 20046352 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
7.64 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
7.64 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.40 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
7.20 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
7.20 | 8888407 |
MESH:D001859 |
Bone Neoplasms |
|
Paclitaxel |
4.22 | 15867366 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
4.95 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
3.89 | 15665606 15845082 15380490 |
MESH:D001943 |
Breast Neoplasms |
|
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
5.40 | 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
5.40 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
dutasteride |
5.40 | 16806904 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
5.40 | 16675129 17018787 12948864 17261762 17289903 14630087 18497071 19861407 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
5.40 | 19217205 18357371 16595493 16110121 16557594 18608205 15136595 |
MESH:D001943 |
Breast Neoplasms |
|
Malathion |
5.40 | 12762645 |
MESH:D001943 |
Breast Neoplasms |
|
Paclitaxel |
5.40 | 18323546 18234424 16273361 18223236 16244791 11325840 15136595 16115903 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
5.40 | 15562024 17614352 16175315 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
5.40 | 20435547 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.08 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
3.56 | 16050911 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
4.28 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
7.19 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
7.19 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
6.04 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
6.04 | 17971768 16332177 16799960 18930000 17088986 17045692 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Paclitaxel |
6.04 | 16313753 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
6.04 | 16507464 15276417 17306315 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
2.83 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
6.82 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
6.82 | 16757204 16280240 17066447 18986760 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
6.82 | 18572023 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.15 | 18670907 16120746 18850075 |
MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
3.25 | 16936243 |
MESH:D002471 |
Cell Transformation, Neoplastic |
marker/mechanism |
|
| 19696165 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
13.90 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cadmium |
13.90 | 17332340 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
13.90 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
13.90 | 19524636 20056578 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.56 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.84 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Lithocholic Acid |
7.67 | 19965603 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.67 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
1.94 | 12621046 8697196 16354765 15340226 15668235 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
2.17 | 17169374 16510598 17287894 17725105 17016597 15001691 18772588 16340194 17018589 17172411 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
2.66 | 18288408 17454858 17255274 18509181 17594712 16303861 15148649 20501625 14970324 18802399 17401013 18383874 16331619 16282729 16391804 17695437 18448328 16524972 18949393 17016601 17094418 15289873 |
MESH:D015179 |
Colorectal Neoplasms |
|
Paclitaxel |
2.66 | 18802399 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.74 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.50 | 20055451 15322242 10048152 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
3.50 | 17688650 16575769 8888407 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
3.50 | 19769572 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.41 | 16733453 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.24 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.57 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.09 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
20-alpha-Dihydroprogesterone |
11.36 | 17187935 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
11.36 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diquat |
5.68 | 18164269 18445702 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
5.68 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
5.68 | 1733752 19641884 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.48 | 11462148 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
3.70 | 1851702 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
4.32 | 9068938 |
MESH:D004487 |
Edema |
|
perfluorooctanoic acid |
9.52 | 17259670 12083418 |
MESH:D004487 |
Edema |
|
pirinixic acid |
9.52 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
9.52 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.51 | 18230668 15322242 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
3.42 | 17692515 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
2.73 | 19148513 18566989 11473722 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
7.84 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
7.84 | 10568697 9294722 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
3.78 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.53 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.74 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.27 | 7562514 6254150 6426943 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
3.92 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
3.68 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
9.50 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
9.50 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
9.50 | 15173087 16481741 17638652 16785472 16337965 |
MESH:D004938 |
Esophageal Neoplasms |
|
Paclitaxel |
9.50 | 16481741 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.73 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
6.60 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
6.60 | 19224547 14986274 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.08 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.50 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
3.77 | 8888407 18558336 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
2.58 | 20067830 |
MESH:D005756 |
Gastritis |
|
Diquat |
5.19 | 15046732 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.30 | 16452187 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.71 | 16145905 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.21 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
3.13 | 15102660 15162350 18337622 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
9.90 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
9.90 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
9.90 | 16080930 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.30 | 20558911 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.00 | 11000095 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Zinc Sulfate |
4.62 | 17063115 |
MESH:D006529 |
Hepatomegaly |
|
perfluorooctanoic acid |
12.31 | 3609246 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
12.31 | 19772884 18467677 19176532 16221962 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
12.31 | 15340226 12621046 16120746 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.56 | 16490937 16863852 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.64 | 15709030 |
MESH:D019247 |
HIV Wasting Syndrome |
|
testosterone enanthate |
5.36 | 17440010 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
2.84 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
8.76 | 17088409 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
8.76 | 14716179 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.48 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.66 | 15340226 16959395 16354765 18606429 8697196 |
MESH:D006930 |
Hyperalgesia |
|
perfluorooctanoic acid |
3.56 | 12083418 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.85 | 20558911 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.76 | 18850075 18670907 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.25 | 16612254 |
MESH:D007022 |
Hypotension |
|
Zinc Sulfate |
4.12 | 7265320 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.03 | 15869954 |
MESH:D007248 |
Infertility, Male |
|
Diquat |
6.46 | 4850670 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
6.46 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
perfluorooctanoic acid |
7.20 | 12083418 |
MESH:D007249 |
Inflammation |
|
Progesterone |
7.20 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
7.20 | 12878042 12200463 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
3.83 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
6.36 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
6.36 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.00 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium |
12.65 | 16226777 16962696 16322080 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
12.65 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
12.65 | 20008137 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
12.65 | 12488133 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
3.93 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
6.47 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
6.47 | 16985049 |
MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Zinc Sulfate |
3.96 | 15237267 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.08 | 16294345 17596541 |
MESH:D007984 |
Leydig Cell Tumor |
|
perfluorooctanoic acid |
4.85 | 8812269 |
MESH:D008080 |
Liposarcoma |
|
Paclitaxel |
4.47 | 17353645 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
4.48 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
4.48 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
4.48 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
4.48 | 16169303 |
MESH:D008113 |
Liver Neoplasms |
|
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
19.51 | 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
19.51 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
19.51 | 15113037 16603448 17045692 18383874 |
MESH:D008113 |
Liver Neoplasms |
|
perfluorooctanoic acid |
19.51 | 18709148 14757943 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
19.51 | 15890375 20007298 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
19.51 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
19.51 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
1.88 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
6.59 | 19095001 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
6.59 | 16863852 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
3.87 | 17228818 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
3.65 | 17365036 |
MESH:D008175 |
Lung Neoplasms |
|
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
7.84 | 18508827 18813816 17139156 9255578 16401635 15172992 14755239 12438228 15893417 16061637 19931552 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
7.84 | 18569708 18520028 18816296 17053015 6695378 20464547 20869020 20064080 20135361 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
7.84 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
7.84 | 17306315 15276417 16712894 17077188 19931552 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
7.84 | 11884234 19555203 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
7.84 | 11062179 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.41 | 15086387 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Paclitaxel |
3.78 | 14749477 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
5.24 | 17203775 11408345 16891317 11807958 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
5.24 | 11408345 17203775 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.09 | 19453300 |
MESH:D008545 |
Melanoma |
|
Paclitaxel |
4.91 | 12025231 12040289 16342250 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
4.91 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Vitamin K 3 |
4.91 | 19082730 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
3.03 | 18303189 16966607 16166281 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
2.92 | 18765137 18803445 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
7.56 | 16381670 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
7.56 | 16757204 18986760 |
MESH:D009101 |
Multiple Myeloma |
|
Paclitaxel |
3.42 | 14749477 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.14 | 16239165 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.69 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
2.93 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
1.98 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.72 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
7.28 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
7.28 | 16411023 |
MESH:D009362 |
Neoplasm Metastasis |
|
Paclitaxel |
3.10 | 15867366 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
10.23 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
10.23 | 18600527 16928823 18239605 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
10.23 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
10.23 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.30 | 20056578 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.35 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
8.26 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
8.26 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
6.50 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
6.50 | 16359493 8888407 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
12.17 | 16436463 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Malathion |
12.17 | 15081274 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Methyl Parathion |
12.17 | 19784758 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
perfluorooctanoic acid |
4.58 | 9802331 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.72 | 20558911 |
MESH:D010014 |
Osteolysis |
|
Paclitaxel |
4.60 | 15867366 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
10.24 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Paclitaxel |
10.24 | 11161223 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
10.24 | 16525653 17393432 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
10.24 | 17306315 15276417 |
MESH:D010190 |
Pancreatic Neoplasms |
|
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
5.21 | 12384795 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
5.21 | 16929163 16500647 19003803 15113037 |
MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
3.72 | 12065085 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.86 | 12520081 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Cadmium |
5.00 | 15687053 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
4.52 | 10923243 |
MESH:D011041 |
Poisoning |
|
Methyl Parathion |
4.69 | 17603234 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.20 | 18163543 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Daunorubicin |
4.56 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
perfluorooctanoic acid |
14.10 | 17132714 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
14.10 | 11222880 11896295 11399792 11118676 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
14.10 | 20603192 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.54 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.04 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cadmium |
2.04 | 17075824 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.04 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
2.04 | 18626508 19082440 |
MESH:D011471 |
Prostatic Neoplasms |
|
Paclitaxel |
2.04 | 17136230 17172428 16729912 16356831 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.04 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
2.04 | 15084515 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.15 | 11422049 12752131 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
2.88 | 17365031 17322281 17975199 15814490 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.69 | 16160472 18286688 15538739 18722050 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.20 | 19058328 |
MESH:D012135 |
Respiratory Sounds |
|
Malathion |
4.90 | 11874814 17119214 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.47 | 18990726 |
MESH:D012140 |
Respiratory Tract Diseases |
|
Malathion |
5.14 | 17119214 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
3.82 | 19155313 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.72 | 18045962 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.02 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.49 | 11738929 1511512 16876388 15475178 14763951 17978042 3137016 11044598 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
2.34 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
15.93 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
15.93 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
15.93 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
15.93 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
15.93 | 16192470 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
3.90 | 15862959 16503802 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
8.57 | 12854658 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
8.57 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.15 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
3.21 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
3.21 | 17522103 17498489 18567086 15786421 18396642 17172411 16951190 19015929 19084572 16424979 |
MESH:D013274 |
Stomach Neoplasms |
|
Paclitaxel |
3.21 | 18506536 18396642 |
MESH:D020521 |
Stroke |
|
Vitamin E |
3.22 | 16517955 |
MESH:D024801 |
Tauopathies |
|
Daunorubicin |
10.65 | 16930453 |
MESH:D024801 |
Tauopathies |
|
Paclitaxel |
10.65 | 16930453 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.51 | 12697716 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.30 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
3.66 | 16280240 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
4.84 | 17262798 |
MESH:D014376 |
Tuberculosis |
|
Chenodeoxycholic Acid |
4.80 | 16040207 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.14 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
4.53 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
4.53 | 17306315 16452187 16712894 11723127 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.27 | 8888407 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
8.39 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
8.39 | 11813266 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.04 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.21 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.86 | 15886252 |